Indeed, we have shown that blockade of NF-κB resolve inflammation in various models of inflammation (Vago et al., 2015, 2016; Barroso et al., 2017), including in a model of gout (Vieira et al., 2017). This evidence concerns the gene NFKB1 and gout.